• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病作为一个全球公共卫生问题:应对方法与倡议——改善全球肾脏病预后组织的立场声明

Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.

作者信息

Levey A S, Atkins R, Coresh J, Cohen E P, Collins A J, Eckardt K-U, Nahas M E, Jaber B L, Jadoul M, Levin A, Powe N R, Rossert J, Wheeler D C, Lameire N, Eknoyan G

机构信息

Tufts-New England Medical Center, Boston, Massachusetts, USA.

出版信息

Kidney Int. 2007 Aug;72(3):247-59. doi: 10.1038/sj.ki.5002343. Epub 2007 Jun 13.

DOI:10.1038/sj.ki.5002343
PMID:17568785
Abstract

Chronic kidney disease (CKD) is increasingly recognized as a global public health problem. There is now convincing evidence that CKD can be detected using simple laboratory tests, and that treatment can prevent or delay complications of decreased kidney function, slow the progression of kidney disease, and reduce the risk of cardiovascular disease (CVD). Translating these advances to simple and applicable public health measures must be adopted as a goal worldwide. Understanding the relationship between CKD and other chronic diseases is important to developing a public health policy to improve outcomes. The 2004 Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference on 'Definition and Classification of Chronic Kidney Disease' represented an important endorsement of the Kidney Disease Outcome Quality Initiative definition and classification of CKD by the international community. The 2006 KDIGO Controversies Conference on CKD was convened to consider six major topics: (1) CKD classification, (2) CKD screening and surveillance, (3) public policy for CKD, (4) CVD and CVD risk factors as risk factors for development and progression of CKD, (5) association of CKD with chronic infections, and (6) association of CKD with cancer. This report contains the recommendations from the meeting. It has been reviewed by the conference participants and approved as position statement by the KDIGO Board of Directors. KDIGO will work in collaboration with international and national public health organizations to facilitate implementation of these recommendations.

摘要

慢性肾脏病(CKD)日益被视为一个全球性的公共卫生问题。现在有令人信服的证据表明,使用简单的实验室检测就能发现CKD,而且治疗可以预防或延缓肾功能下降的并发症,减缓肾病进展,并降低心血管疾病(CVD)风险。必须将这些进展转化为简单且适用的公共卫生措施,并将其作为全球范围内的目标。了解CKD与其他慢性疾病之间的关系对于制定改善治疗效果的公共卫生政策很重要。2004年全球改善肾脏病预后组织(KDIGO)关于“慢性肾脏病的定义和分类”的争议会议,标志着国际社会对肾脏病预后质量倡议组织关于CKD的定义和分类的重要认可。2006年KDIGO关于CKD的争议会议召开以审议六个主要议题:(1)CKD分类;(2)CKD筛查和监测;(3)CKD公共政策;(4)作为CKD发生和进展风险因素的CVD及CVD风险因素;(5)CKD与慢性感染的关联;(6)CKD与癌症的关联。本报告包含了会议的建议。它已经过会议参与者审阅,并被KDIGO董事会批准为立场声明。KDIGO将与国际和国家公共卫生组织合作,以促进这些建议的实施。

相似文献

1
Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.慢性肾脏病作为一个全球公共卫生问题:应对方法与倡议——改善全球肾脏病预后组织的立场声明
Kidney Int. 2007 Aug;72(3):247-59. doi: 10.1038/sj.ki.5002343. Epub 2007 Jun 13.
2
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).慢性肾脏病的定义与分类:来自改善全球肾脏病预后组织(KDIGO)的立场声明
Kidney Int. 2005 Jun;67(6):2089-100. doi: 10.1111/j.1523-1755.2005.00365.x.
3
KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.KDIGO 美国评论:2012 年 KDIGO 慢性肾脏病评估与管理临床实践指南
Am J Kidney Dis. 2014 May;63(5):713-35. doi: 10.1053/j.ajkd.2014.01.416. Epub 2014 Mar 16.
4
Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).慢性肾脏病贫血临床实践指南:问题与解决方案。来自改善全球肾脏病预后组织(KDIGO)的立场声明。
Kidney Int. 2008 Nov;74(10):1237-40. doi: 10.1038/ki.2008.299. Epub 2008 Jul 2.
5
The contribution of chronic kidney disease to the global burden of major noncommunicable diseases.慢性肾脏病对主要非传染性疾病全球负担的贡献。
Kidney Int. 2011 Dec;80(12):1258-70. doi: 10.1038/ki.2011.368. Epub 2011 Oct 12.
6
Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention.预防慢性肾脏病发生、进展及并发症的综合公共卫生策略:疾病控制与预防中心召集的专家小组报告
Am J Kidney Dis. 2009 Mar;53(3):522-35. doi: 10.1053/j.ajkd.2008.11.019.
7
Conceptual model of CKD: applications and implications.慢性肾脏病的概念模型:应用与启示
Am J Kidney Dis. 2009 Mar;53(3 Suppl 3):S4-16. doi: 10.1053/j.ajkd.2008.07.048.
8
A new initiative in nephrology: 'Kidney disease: improving global outcomes'.肾脏病学的一项新倡议:“肾脏疾病:改善全球预后”
Contrib Nephrol. 2005;149:90-99. doi: 10.1159/000085462.
9
The burden of kidney disease: improving global outcomes.肾脏疾病负担:改善全球预后。
Kidney Int. 2004 Oct;66(4):1310-4. doi: 10.1111/j.1523-1755.2004.00894.x.
10
Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).肾性骨营养不良的定义、评估及分类:改善全球肾脏病预后组织(KDIGO)的立场声明
Kidney Int. 2006 Jun;69(11):1945-53. doi: 10.1038/sj.ki.5000414.

引用本文的文献

1
Quality of care for people with chronic kidney disease: a systematic review and meta-analysis.慢性肾病患者的护理质量:一项系统综述与荟萃分析
BMJ Open. 2025 Sep 4;15(9):e102044. doi: 10.1136/bmjopen-2025-102044.
2
Beyond Blood Pressure: Emerging Pathways and Precision Approaches in Hypertension-Induced Kidney Damage.超越血压:高血压所致肾损伤的新兴途径与精准方法
Int J Mol Sci. 2025 Aug 6;26(15):7606. doi: 10.3390/ijms26157606.
3
Fibrosis-4 index as a predictor of all-cause and cardiovascular mortality in patients with chronic kidney disease.
纤维化-4指数作为慢性肾脏病患者全因死亡率和心血管死亡率的预测指标
PLoS One. 2025 Aug 1;20(8):e0329315. doi: 10.1371/journal.pone.0329315. eCollection 2025.
4
Prolyl Hydroxylase Inhibitor-Mediated HIF Activation Drives Transcriptional Reprogramming in Retinal Pigment Epithelium: Relevance to Chronic Kidney Disease.脯氨酰羟化酶抑制剂介导的低氧诱导因子激活驱动视网膜色素上皮细胞的转录重编程:与慢性肾脏病的相关性
Cells. 2025 Jul 21;14(14):1121. doi: 10.3390/cells14141121.
5
Ultra-Sensitive Quantification of Indoxyl Sulfate and 3-Carboxy-4-Methyl-5-Propyl-2-Furanpropanoic Acid in Plasma Using Ultra-Performance Liquid Chromatography Coupled to Quadrupole Time-of-Flight Mass Spectrometry.使用超高效液相色谱-四极杆飞行时间质谱联用技术对血浆中硫酸吲哚酚和3-羧基-4-甲基-5-丙基-2-呋喃丙酸进行超灵敏定量分析。
J Clin Lab Anal. 2025 Aug;39(16):e70077. doi: 10.1002/jcla.70077. Epub 2025 Jul 11.
6
Odor olfactory dysfunction in chronic kidney disease and diabetes mellitus and its association with nutritional factors.慢性肾脏病和糖尿病中的嗅觉功能障碍及其与营养因素的关联。
Caspian J Intern Med. 2025 Mar 21;16(2):289-296. doi: 10.22088/cjim.16.2.289. eCollection 2025 Spring.
7
Incidence, progression and predictors of chronic kidney disease among adult HIV/AIDS patients on antiretroviral treatment in comprehensive specialised hospitals in the Amhara Region, Ethiopia, 2022: a multi-centre retrospective follow-up study.2022年埃塞俄比亚阿姆哈拉地区综合专科医院接受抗逆转录病毒治疗的成年艾滋病毒/艾滋病患者慢性肾脏病的发病率、进展及预测因素:一项多中心回顾性随访研究
BMJ Open. 2025 Jul 8;15(7):e090345. doi: 10.1136/bmjopen-2024-090345.
8
Associations of cystatin C with incident chronic kidney disease and all-cause mortality in patients with normal glucose tolerance and prediabetes.胱抑素C与糖耐量正常和糖尿病前期患者新发慢性肾脏病及全因死亡率的关联。
Sci Rep. 2025 Jul 2;15(1):23092. doi: 10.1038/s41598-025-07159-3.
9
Klotho Suppresses Indoxyl Sulfate-Mediated Apoptosis in Human Kidney Proximal Tubular (HK-2) Cells through Modulating the AKT/Nrf2 Mechanism.α-klotho通过调节AKT/Nrf2机制抑制硫酸吲哚酚介导的人肾近端小管(HK-2)细胞凋亡。
ACS Omega. 2025 Jun 3;10(23):24018-24029. doi: 10.1021/acsomega.4c08038. eCollection 2025 Jun 17.
10
Stability indicating RP-HPLC method for estimation of finerenone and its related substances in new dosage form.用于测定新剂型中非奈利酮及其有关物质的稳定性指示反相高效液相色谱法
Sci Rep. 2025 Jun 20;15(1):20229. doi: 10.1038/s41598-025-07166-4.